Quantrx Biomedical CorpOOTC QTXB Stock Report

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. The company is headquartered in Tualatin, Oregon. The firm is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The firm's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. The company also owns certain diagnostic testing technology that is based on our lateral flow patents.